Table 3. Comparison of pain between the mefenamic acid and exercise group in the first cycle.
Pain | Mefenamic acid | Exercise | p-value | |
---|---|---|---|---|
Pain intensity, cm | 39.0±17.8 (34.46–43.56) |
45.4±19.2 (40.50–50.34) |
0.058 | |
Pain duration, days | 1.4±0.6 (1.2–1.6) |
1.6±0.8 (1.38–1.79) |
0.131 | |
Pain reduction between baseline and the second cycle, mean (SE) | 16.0 (2.2) | 14.8 (2.5) | 0.724 | |
Severity of dysmenorrhea, n (%) | 0.475 | |||
Mild | 22 (52.4) | 20 (47.6) | ||
Moderate | 35 (51.5) | 33 (48.5) | ||
Severe | 4 (33.3) | 8 (66.7) |
Data given as mean ± SD and (95% confidence interval for mean) unless otherwise stated. SE: standard error.